Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 18:60:101810.
doi: 10.1016/j.gore.2025.101810. eCollection 2025 Aug.

Assessing delays in accessing and completing radiotherapy for cervical cancer treatment: A multicenter survey of oncology providers in go further-funded countries in Sub-Saharan Africa

Caroline G Kernell  1 , Megan Kassick  2   3 , Jessica M George  4 , Chidinma P Anakwenze  5 , Edward L Trimble  6 , Surbhi Grover  2   3
Affiliations

Assessing delays in accessing and completing radiotherapy for cervical cancer treatment: A multicenter survey of oncology providers in go further-funded countries in Sub-Saharan Africa

Caroline G Kernell et al. Gynecol Oncol Rep. .

Abstract

Objective: Cervical cancer is a leading cause of cancer death in Sub-Saharan Africa. Go Further provides funds for prevention and screening in Sub-Saharan Africa, but access to treatment for invasive disease remains limited. This survey aims to assess delays in accessing curative-intent chemoradiotherapy for cervical cancer in countries receiving Go Further funding.

Methods: Oncology providers in countries receiving Go Further funding (Botswana, Eswatini, Ethiopia, Kenya, Lesotho, Malawi, Mozambique, Namibia, Tanzania, Uganda, Zambia, Zimbabwe) and South Africa were invited to participate in a web-based survey beginning September 2023.

Results: Fifteen oncology providers responded, with all countries except Malawi represented. Nearly half (46.3 %) reported wait time of ≥two months for chemoradiotherapy consultation. 93.3 %, 71.4 %, 53.7 % and 73.3 % had access to at least one CT, linear accelerator, cobalt, and brachytherapy machine, respectively. Majority (60 %) reported wait time of <one month to initiate chemoradiotherapy after staging. However, 28.6 % reported >95 % of patients complete external radiotherapy within 42 days, and 33 % reported >95 % of these patients receive brachytherapy. Only 26.7 % reported overall treatment time within 56 days for >95 % of patients. Lack of transportation, funding, and patient fear, were other treatment barriers reported.

Conclusion: These results highlight the need for additional chemoradiotherapy resources in Go Further-funded countries. In addition to expanding radiotherapy, supplemental avenues to improve access in Sub-Saharan Africa include addressing barriers that increase wait times along the care continuum and implementing social support. This survey serves as a call to Go Further, highlighting the urgent need for resource allocation for cervical cancer treatment.

Keywords: Access to healthcare; Cervical cancer; Global health; Radiation oncology; Radiotherapy; Sub-Saharan countries.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: SG reports consulting fees for Lumonus, Harbinger Health, and Sustainable Dialogue for Peaceful Uses (SDPU) for serving as a scientific advisor. All other authors report no conflict of interest.

Figures

Fig. 1
Fig. 1
Distribution of survey responses across Sub-Saharan Africa.
See this image and copyright information in PMC

References

    1. Aderinto N. Diagnosing the disparities: an analysis of the current state of medical imaging in Africa and strategies for improvement: a correspondence. IJS Global Health. 2023;6(3):e138.
    1. Agency IAE, 2025. Directory of Radiotherapy Centers 2025 [Available from: https://dirac.iaea.org/Query/StatusRTE].
    1. Anakwenze C., Bhatia R., Rate W., Bakwenabatsile L., Ngoni K., Rayne S., et al. Factors related to advanced stage of cancer presentation in botswana. J Glob Oncol. 2018;4:1–9. - PMC - PubMed
    1. Arbyn M., Raifu A.O., Weiderpass E., Bray F., Anttila A. Trends of cervical cancer mortality in the member states of the European Union. Eur. J. Cancer. 2009;45(15):2640–2648. - PubMed
    1. Arbyn M., Weiderpass E., Bruni L., de Sanjosé S., Saraiya M., Ferlay J., et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob. Health. 2020;8(2):e191–e203. - PMC - PubMed

LinkOut - more resources